nach oben

Erschienen in:

01.12.2006 | Original Paper

Ethical Issues in Cancer Genetics: 1) Whose Information Is It?

verfasst von: Katherine A. Schneider, Anu B. Chittenden, Kelly J. Branda, Meredith A. Keenan, Steven Joffe, Andrea Farkas Patenaude, Hazel Reynolds, Karin Dent, Sonja Eubanks, Jill Goldman, Bonnie Leroy, Nancy Steinberg Warren, Kelly Taylor, Cate Walsh Vockley, Judy E. Garber

Erschienen in: Journal of Genetic Counseling | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

This article presents and discusses four clinical cases that exemplify the complexity of ethical dilemmas concerning the provider’s obligation to disclose or withhold genetic information from patients.

Case 1: What is the responsibility of the cancer genetics provider to ensure that a positive test results is shared with distant relatives?

Case 2: To ensure that results go to at-risk relatives, do we have the right to ignore the wishes of the designated next-of-kin?

Case 3: Do we have the right to reveal a familial BRCA1 mutation to a patient’s relative, who is at 50% risk?

Case 4: Do we have an obligation to reveal that a patient is not a blood relative and therefore, not at risk to have inherited a familial mutation?

These cases form the basis for discussing the provider’s dual obligations to keeping patient confidentiality and informing patients and families about risk (i.e. duty to warn). We also provide a summary of consensus points and additional discussion questions for each case.

American Society of Clinical Oncology (2003). American Society of Clinical Oncology Policy Statement Update: Genetic testing for cancer susceptibility. J Clin Oncol, 21, 2397–2406.CrossRef

American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure (1998). ASHG statement: Professional disclosure of familial genetic information. Am J Hum Genet, 61, 474–483.CrossRef

Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, A., Eyfjord, E., Hopper, J. L., et al. (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet, 72, 1117–1130.PubMedCrossRef

Bower, M. A., McCarthy Veach, P., Bartels, D. M., & LeRoy, B. S. (2002). A survey of genetic counselors’ strategies for addressing ethical and professional challenges in practice. J Genet Counsel, 11, 163–186.CrossRef

Bryant, J., Baggott la Velle, L., & Searle, J. (2005). Ethics and Bioethics. In Introduction to Bioethics (pp. 17–28). West Sussex, England: John Wiley & Sons.

Di Pietro, M. L., Giuli, A., & Spagnolo, A. G. (2004). Ethical implications of predictive DNA testing for hereditary breast cancer. Annals of Oncol, 15(suppl 1), i65–i70.CrossRef

Doukas, D. J. (2003). Genetics providers and the family covenant: connecting individuals with their families. Genet Test, 7, 315–321.PubMedCrossRef

Forrest, K., Simpson, S. A., Wilson, B. J., van Teijllingen, E. R., McKee, L., Haites, N., et al. (2003). To tell or not to tell: Barriers and facilitators in family communication about genetic risk. Clin Genet, 64, 317–326.PubMedCrossRef

Gaff, C. L., Collins, V., Symes, T., & Halliday, J. (2005). Facilitating family communication about predictive genetic testing: Probands’ perceptions. J Genet Counsel, 14, 133–140.CrossRef

Garber, J. E., Goldstein, A. M., Kantor, K. F., Dreyfus, M. G., Fraumeni, J. F. Jr., & Li, F. P. (1991). Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res, 51, 6094–6097.PubMed

Harris, M., & Winship, I. (2005). Controversies and ethical issues in cancer-genetics clinics. Lancet Oncol, 6, 301–310.PubMedCrossRef

Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., et al. (2001). Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. Natl Cancer Inst, 93, 1633–1637.

Jarvinen, H. J., Aarnio, M., Mustonen, H., Aktan-Collan, K., Aaltonen, L. A., Peltomake, P., et al. (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary non-polyposis colorectal cancer. Gastroenterology, 118, 829–834.PubMedCrossRef

Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., et al. (2002). Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med, 346, 1609–1615.PubMedCrossRef

Maley, J. A. (1994). An Ethics Casebook for Genetic Counselors. Wallingford, PA: A publication of the National Society of Genetic Counselors, Inc.

McGivern, B., Everett, J., Yager, G. G., Baumiller, R. C., Hafertepen, A, & Saal, H. M. (2004). Family communication about positive BRCA1 and BRCA2 genetic test results. Genet Med, 6, 503–509.PubMedCrossRef

National Society of Genetic Counselors (1992). National Society of Genetic Counselors Code of Ethics. J Genetic Counsel, 1, 41–43.CrossRef

Patenaude, A. (2005) Cancer Genes and Cancer Risk. In Genetic Testing for Cancer: Psychological Approaches for helping Patients and Families (pp. 41–73). Washington DC: American Psychological Association.

Pentz, R. D., Peterson, S. K., Watts, B., Vernon, S. W., Lynch, P. M., Koehly, L. M., et al. (2005). Hereditary nonpolyposis colorectal cancer family members’ perceptions about the duty to inform and health professionals’ role in disseminating genetic information. Genetic Testing, 9, 261–268.PubMedCrossRef

Safer v Estate of Pack (1996). 677 A.2d 1188, NJ Super A.D.

Schneider, K. A., & Li, F. (Updated 10/12/2004). Li-Fraumeni syndrome. In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online). Copyright, University of Washington, Seattle. 1997–2006. Available at http://www.genetests.org. Accessed January 17, 2005.

Smith, D. H., Quaid, K. A., Dworkin, R. B., Gramelspacher, G. P., Granbois, J. A., & Vance, G. H. (1998). Guideline V: Confidentiality. In Early Warning: Cases and ethical guidance for presymptomatic testing in genetic diseases. (pp. 144–148) Bloomington, Indiana: Indiana University Press.

Suthers, G. K., Armstrong, J., McCormack, J., and Trott, D. (2005). Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J Med Genet, (epub, in press).

Trepanier, A., Ahrens, M., McKinnon, W., Peters, J., Stopfer, J., Campbell Grumet, S., et al. (2004). Genetic Cancer Risk Assessment and Counseling: Recommendations of the National Society of Genetic Counselors. J Genet Counsel, 13, 83–114.CrossRef

United States Department of Health and Human Services. Healthcare Insurance Portability and Accountability Act of 1996 and Amendments. 164.512(j). Available at: http://www.hhs.gov/ocr/hipaa Accessed on-line on January 17, 2005.

Vasen, H. F., Wijnen, J. T., Menko, F. H., Kleibeuker, J. H., Taal, B. G., Griffioen, G., et al. (1996). Cancer risk in families with hereditary nonpoyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology, 110, 1020–1027.PubMedCrossRef

Titel: Ethical Issues in Cancer Genetics: 1) Whose Information Is It?
verfasst von: Katherine A. Schneider
Anu B. Chittenden
Kelly J. Branda
Meredith A. Keenan
Steven Joffe
Andrea Farkas Patenaude
Hazel Reynolds
Karin Dent
Sonja Eubanks
Jill Goldman
Bonnie Leroy
Nancy Steinberg Warren
Kelly Taylor
Cate Walsh Vockley
Judy E. Garber
Publikationsdatum: 01.12.2006
Verlag: Kluwer Academic Publishers-Plenum Publishers
Erschienen in: Journal of Genetic Counseling / Ausgabe 6/2006
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-006-9053-4

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Ethical Issues in Cancer Genetics: 1) Whose Information Is It?

Abstract

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2006

A Survey of Patients’ Experiences with the Cancer Genetic Counseling Process: Recommendations for Cancer Genetics Programs

The Complexity and Challenges of Genetic Counseling and Testing for Inflammatory Bowel Disease

Spiritual Coping, Family History, and Perceived Risk for Breast Cancer—Can We Make Sense of it?

Evolution of the Colored Eco-Genetic Relationship Map (CEGRM) for Assessing Social Functioning in Women in Hereditary Breast-Ovarian (HBOC) Families

If We Build It … Will They Come? – Establishing a Cancer Genetics Services Clinic for an Underserved Predominantly Latina Cohort

Better the Devil You Know? High-Risk Individuals’ Anticipated Psychological Responses to Genetic Testing for Melanoma Susceptibility

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie